Stay Updated with the Latest VISEN Pharmaceuticals 2561.HK News in Real Time
Find 2561.HK news now at Meyka AI. Stay informed with the latest VISEN Pharmaceuticals stocks updates, including price news, market analysis, and expert insights.
AstraZeneca Shares Plunge 7.4% After Heart Drug Trial Fails—July 10
AstraZeneca stock fell 7.4% after Wainua heart drug trial missed primary goal. Jefferies models $2.5B sales loss. Meyka grades AZN B+, forecasts $131.71 by year-end.
Blue Jet Healthcare (NSE: BLUEJET) Surges 8.5% After Raising ₹800 Crore Through QIP at ₹506 Per Share
Blue Jet Healthcare shares jumped as much as 8.5% on July 10, 2026. The rally followed the company’s ₹800 crore fundraise through a Qualified Institutional Placement. Blue Jet Healthcare allotted 15,810,276 equity shares at ₹506 each, a discount to the floor price. The QIP window ran from July 6 to July 9, 2026, before the…
AstraZeneca (LON: AZN) Shares Plunge Up to 9% After Wainua Misses Primary Endpoint in Late-Stage Trial
AstraZeneca shares plunged as much as 9.55% on Thursday, July 9, 2026, after a major trial setback. The company’s heart drug Wainua failed to meet its primary endpoint in a Phase III study. That single announcement wiped out between £19 billion and £20 billion in market value. AstraZeneca’s market capitalization fell below £200 billion, though…
FTSE 100 Falls 0.49% as U.S.-Iran Tensions Escalate; AstraZeneca Slumps After Late-Stage Trial Failure
The FTSE 100 traded lower on Thursday, July 9, 2026, down roughly 0.5% during the morning session. AstraZeneca shares plunged as much as 9.55%, wiping out nearly £19 billion in market value. That single stock drove almost all of London’s underperformance versus other European indices. Germany’s DAX gained 0.4%, while France’s CAC 40 rose 0.45%…
European Markets: FTSE 100 Gains 0.26%, CAC 40 Climbs 0.30% as Geopolitical Risks Remain in Focus
FTSE 100 edged higher on July 6 as European equities opened the week with cautious gains despite ongoing geopolitical concerns. The UK’s benchmark index rose 0.26%, while France’s CAC 40 advanced 0.30% during early trading. Germany’s DAX also traded modestly higher as investors monitored developments in the Middle East, global trade discussions, and expectations for…
FTSE 100 Up 0.16% After UK GDP Growth Accelerates, While Pound Dips to $1.3245
The FTSE 100 moved higher on Monday as investors welcomed stronger UK economic data and looked past ongoing global uncertainty. The benchmark index gained after official figures confirmed that the UK economy expanded faster than expected during the first quarter. At the same time, the British pound weakened against the US dollar, giving support to…
Diksha Polymers Share Price Hits 5% Upper Circuit After 2.23% Listing Premium, Up 7.32%
Diksha Polymers made a positive debut on the BSE SME platform on June 24, 2026. The stock is listed at ₹114.50, a 2.23% premium over its IPO price of ₹112 per share. Buying interest remained strong after listing, pushing the share price to its 5% upper circuit of ₹120.20, taking the gain to 7.32% above…
Aurobindo Pharma (NSE: AUROPHARMA) Shares Slip Despite US FTC Approval for $250 Million Lannett Acquisition
Aurobindo Pharma shares edged lower on June 22, 2026, despite a significant regulatory win announced before market open. Aurobindo Pharma USA, a wholly-owned subsidiary, received approval from the US Federal Trade Commission to proceed with the $250 million acquisition of Lannett Company LLC on a cash-free, debt-free basis. It inclusive of normalized working capital, with…
Idorsia Stock Surges 24% on Debt Refinancing Deal, June 19
Idorsia stock surges 24% to 5.78 CHF after refinancing debt and extending liquidity to 2028. Swiss biotech advances insomnia drug development.